Leon Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 14
Employees
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 9

Leon General Information

Description

Developer of drugs through nanoscience designed to offer better patient outcomes. The company's drugs specialize in improving the bioavailability of poorly water-soluble medicine by using their proprietary technology to create either polymeric or crystalline nanoparticles, enabling medical professionals to get nano-formulated drugs with meaningful differentiation and added benefits.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • Kopernikusstraße 9
  • 81679 Munich
  • Germany
+49 089 000000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Leon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 000.00 Completed Generating Revenue
2. Later Stage VC (Series B) 16-Apr-2020 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 27-Jul-2015 $20.5M $20.5M 0000 Completed Generating Revenue
To view Leon’s complete valuation and funding history, request access »

Leon Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of drugs through nanoscience designed to offer better patient outcomes. The company's drugs specialize in impr
Drug Discovery
Munich, Germany
14 As of 2021
000.00
000000 - 000 000.00

00000000

esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt i
000000000000000
Gordon, Australia
000.00
000000000 000.00

00000000

quip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum
0000 000000000
Jersey City, NJ
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Leon Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Noxopharm Corporation Gordon, Australia 000.00 000000000 000.00
00000000 Formerly VC-backed Jersey City, NJ 00 00000 000000000 00000
0000000 0000000000 Formerly VC-backed Waltham, MA 00 00000 000000000 00000
000000000 00000000 Formerly VC-backed Vancouver, Canada 000 000.00 000000&0 000.00
000000 00000000000 Corporate Backed or Acquired Richmond, CA 000000000 -
You’re viewing 5 of 14 competitors. Get the full list »

Leon Executive Team (7)

Name Title Board Seat Contact Info
Andrea Cusack Chief Executive Officer
Christian Nafe Chief Financial Officer
Pascale Clement Ph.D Chief Technology Officer
Wolfgang Beier Co-Founder, Medical Director & Chief Scientific Officer
Anne Burger Director, Finance
You’re viewing 5 of 7 executive team members. Get the full list »

Leon Board Members (13)

Name Representing Role Since
Cornelia Beier Leon Co-Founder & Board Member 000 0000
Enno Spillner Evotec Supervisory Board Member 000 0000
Frank Mathias Ph.D Self Supervisory Board Member 000 0000
Gerhard Ries Ph.D LifeCare Partners Supervisory Board Member 000 0000
Hubert Birner Ph.D TVM Capital Life Science Chairman of the Supervisory Board 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Leon Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Leon Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bayerische Beteiligungsgesellschaft PE/Buyout Minority 000 0000 000000 0
Eckenstein-Geigy-Stiftung Not-For-Profit Venture Capital Minority 000 0000 000000 0
Evotec Corporation Minority 000 0000 000000 0
Albany Private Equity Holding Angel (individual) Minority 000 0000 000000 0
CBoneHolding Other Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »